Body Composition

Osteosarcopenia in Older Adults With Rheumatoid Arthritis: Clinical Correlates and Its Association With Rheumatoid Cachexia.

TL;DR

Osteosarcopenia was more than twice as common in older patients with RA than in matched controls, and rheumatoid cachexia remained independently associated with osteosarcopenia, supporting osteosarcopenia as a distinct catabolic phenotype in RA.

Key Findings

Osteosarcopenia was more than twice as prevalent in older patients with rheumatoid arthritis compared to age- and sex-matched controls.

  • Osteosarcopenia prevalence was 28.4% in RA patients versus 10.4% in controls (p < 0.001).
  • The study included 134 RA patients aged ≥60 years and 134 age- and sex-matched controls (total N = 268).
  • This was a retrospective cross-sectional study design.
  • Sarcopenia was defined using an EWGSOP2-aligned approach and osteoporosis according to WHO criteria.

Sarcopenia and osteoporosis were each individually more prevalent in RA patients than in controls.

  • Sarcopenia prevalence was 49.3% in RA patients versus 20.9% in controls (p < 0.001).
  • Osteoporosis prevalence was 53.0% in RA patients versus 32.1% in controls (p < 0.001).
  • All between-group comparisons for sarcopenia, osteoporosis, and osteosarcopenia were statistically significant at p < 0.001.

Patients with RA had significantly lower BMI, fat-free mass index, and fat mass index compared to controls.

  • BMI, FFMI, and FMI were all lower in RA patients compared to controls (all p ≤ 0.001).
  • Visceral fat did not differ significantly between RA patients and controls.
  • Body composition was assessed using bioelectrical impedance analysis.
  • FFMI (fat-free mass index) and FMI (fat mass index) were key body composition parameters evaluated.

Rheumatoid cachexia was highly prevalent within the osteosarcopenia subgroup and remained independently associated with osteosarcopenia after multivariable adjustment.

  • RC prevalence among RA patients with osteosarcopenia was 39.5%.
  • RC was defined as FFMI < 10th percentile and FMI > 25th percentile.
  • After adjustment for demographic, comorbidity, and RA-specific factors, RC remained independently associated with osteosarcopenia (adjusted OR 10.43, 95% CI 3.13–34.79; p < 0.001).
  • This represents one of the strongest independent associations identified in the multivariable model.

Osteosarcopenia in RA was associated with lower serum albumin levels and greater functional impairment.

  • Within the RA group, osteosarcopenia was associated with lower serum albumin levels.
  • Osteosarcopenia was associated with lower IADL (Instrumental Activities of Daily Living) scores, assessed using the Lawton-Brody IADL scale.
  • Nutritional risk was assessed using the MNA-SF (Mini Nutritional Assessment Short Form).
  • These associations characterize osteosarcopenia as 'a distinct catabolic phenotype in RA.'

The authors characterize osteosarcopenia as a distinct catabolic phenotype in RA, defined by rheumatoid cachexia, lower serum albumin, and greater functional impairment.

  • The findings support osteosarcopenia as representing a convergence of muscle loss, bone loss, and abnormal body composition (cachexia) specific to RA.
  • RC clustered within the osteosarcopenia subgroup, suggesting shared pathophysiological mechanisms.
  • The study calls for integrated screening of bone and muscle health alongside nutritional and functional assessment in older RA patients.

What This Means

This research suggests that older adults with rheumatoid arthritis (RA) face a dramatically higher risk of a condition called osteosarcopenia — the simultaneous loss of both muscle mass and bone density — compared to people of the same age and sex without RA. In this study of 134 RA patients aged 60 and older, nearly 1 in 3 had osteosarcopenia, compared to about 1 in 10 of matched controls. Similarly, sarcopenia (muscle loss alone) and osteoporosis (bone loss alone) were each roughly twice as common in RA patients. The study also found that RA patients overall had lower body weight and lower measures of both fat and muscle mass than controls, even though visceral (abdominal) fat was similar between groups. A key finding was the strong link between osteosarcopenia and a condition called rheumatoid cachexia — a specific pattern in RA where patients lose muscle but retain or gain fat, particularly measured as very low lean mass combined with relatively high fat mass. Nearly 40% of RA patients with osteosarcopenia also had rheumatoid cachexia, and this association held even after accounting for age, other health conditions, and RA-specific disease factors (the adjusted odds ratio was over 10). Patients with osteosarcopenia also had lower blood albumin levels (a marker of nutritional status) and greater difficulty performing everyday tasks like managing finances, cooking, or using transportation. This research suggests that osteosarcopenia in older RA patients is not simply a coincidence of two separate conditions but may represent a distinct biological state driven by chronic inflammation, poor nutrition, and muscle-bone metabolic disruption. Clinicians caring for older adults with RA may benefit from routinely evaluating both muscle and bone health together, alongside nutritional status and functional ability, to identify those at highest risk of physical decline.

Check Your Own Numbers

Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.

Upload Your Labs

Have a question about this study?

Citation

Ozer F, Sunkak S, Bilgili Z, &#x15e;en &, G&#xfc;ven E. (2026). Osteosarcopenia in Older Adults With Rheumatoid Arthritis: Clinical Correlates and Its Association With Rheumatoid Cachexia.. Geriatrics &amp; gerontology international. https://doi.org/10.1111/ggi.70847